Keywords: wyeth, guidance, up, last, drug, major, says

Wyeth's 2006 guidance up 10% on last year

Article | 16 January 2006

Print This

US drug major Wyeth says it expects pro forma diluted earnings per share for 2006 to be $2.97-$3.07, excluding any potential ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in